Combination therapy vs. monotherapy in type 2 diabetes

21 Sept 2016


Published online in Diabetes, Obesity and Metabolism, a study by researchers in South Korea found gemigliptin combined with metformin is superior to monotherapy with either drug for the treatment of type 2 diabetes.

Endocrinology Advisor


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story